drugset / Trial / NCT01043172
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Phase 2
Completed
72 enrolled
National Cancer Center, Korea
Dong-A Pharmaceutical Co., Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
The investigators propose to evaluate efficacy and safety of gemcitabine in the adjuvant treatment of cholangiocarcinoma after potentially curative treatment with surgical resection.
Timeline
- Start
- 2009-07-20
- Primary completion
- 2016-12-31
- Completion
- 2016-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |